Athersys, Inc. (ATHX) was a big mover last session, as the company saw its shares rise nearly 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company, as the stock is now up 13.4% over the past one month time frame.
The company has seen a mixed track record when it comes to estimate revisions, of one increase and one decrease over the past one month, while the Zacks Consensus Estimate has remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Athersys currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Some better ranked med-biomed/gene stocks include Actelion Ltd. (ALIOF), Neuralstem, Inc. (CUR) and GeoVax Labs, Inc. (GOVX). While Actelion and Geovax Labs hold a Zacks Rank #1 (Strong Buy), Neuralstem carries a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
ATHERSYS INC (ATHX): Free Stock Analysis Report
ACTELION LTD (ALIOF): Free Stock Analysis Report
NEURALSTEM INC (CUR): Free Stock Analysis Report
GEOVAX LABS INC (GOVX): Free Stock Analysis Report
Zacks Investment Research
- Finance Trading
- Personal Investing Ideas & Strategies